Inspire Investing LLC Has $1.28 Million Stock Holdings in Cabot Co. (NYSE:CBT)

Inspire Investing LLC increased its position in Cabot Co. (NYSE:CBT) by 202.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,462 shares of the specialty chemicals company’s stock after buying an additional 7,671 shares during the quarter. Inspire Investing LLC’s holdings in Cabot were worth $1,281,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the business. UMB Bank n.a. increased its position in Cabot by 53.9% in the 3rd quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company’s stock valued at $41,000 after acquiring an additional 130 shares during the period. CWM LLC grew its stake in shares of Cabot by 60.6% in the second quarter. CWM LLC now owns 416 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 157 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in Cabot by 33.4% in the second quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company’s stock valued at $48,000 after purchasing an additional 119 shares during the period. 1620 Investment Advisors Inc. bought a new position in Cabot during the 2nd quarter worth $49,000. Finally, Mather Group LLC. acquired a new position in Cabot during the 2nd quarter worth about $58,000. Institutional investors own 93.18% of the company’s stock.

Insider Buying and Selling at Cabot

In other news, CEO Sean D. Keohane sold 25,617 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the transaction, the chief executive officer now owns 331,174 shares of the company’s stock, valued at $33,630,719.70. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, CFO Erica Mclaughlin sold 23,274 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the completion of the sale, the chief financial officer now owns 59,814 shares in the company, valued at $5,968,839.06. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Sean D. Keohane sold 25,617 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total value of $2,601,406.35. Following the completion of the transaction, the chief executive officer now owns 331,174 shares in the company, valued at approximately $33,630,719.70. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 71,939 shares of company stock valued at $7,308,812. Corporate insiders own 3.07% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on CBT shares. StockNews.com cut Cabot from a “strong-buy” rating to a “buy” rating in a research note on Monday, June 24th. JPMorgan Chase & Co. increased their target price on shares of Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a research report on Wednesday, August 7th. Finally, UBS Group dropped their price target on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $101.75.

Cabot Stock Up 1.5 %

Shares of Cabot stock opened at $112.41 on Monday. The stock’s 50-day moving average is $104.12 and its 200 day moving average is $98.99. Cabot Co. has a one year low of $65.10 and a one year high of $113.12. The firm has a market cap of $6.21 billion, a price-to-earnings ratio of 14.23, a PEG ratio of 0.93 and a beta of 1.19. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.22 and a quick ratio of 1.45.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, August 5th. The specialty chemicals company reported $1.92 EPS for the quarter, topping the consensus estimate of $1.72 by $0.20. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1 billion. During the same quarter last year, the firm posted $1.42 EPS. The company’s quarterly revenue was up 5.0% on a year-over-year basis. Equities research analysts anticipate that Cabot Co. will post 7.07 EPS for the current year.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.